<DOC>
	<DOCNO>NCT00035555</DOCNO>
	<brief_summary>The purpose study determine whether treatment Belatacept ( BMS-224818 ) efficacious treatment cyclosporine prevent acute rejection superior safety/tolerability profile ( good kidney function blood pressure , few lipid problem , less diabetes mellitus ) .</brief_summary>
	<brief_title>Study Comparing Safety Efficacy Belatacept With That Cyclosporine Patients With Transplanted Kidney</brief_title>
	<detailed_description />
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Key inclusion criterion Recipients first kidney transplant Key exclusion criterion Those high risk acute allograft rejection , include receive second renal transplant , history panel reactive antibody level &gt; 20 % , consider investigator relatively high risk acute rejection Human leukocyte antigenidentical donorrecipient pair Cold ischemia time &gt; 36 hour ( donor kidney ) Participants positive hepatitis C antibody , polymerase chain reaction , hepatitis B surface antigen , human immunodeficiency virus A positive purify protein derivative tuberculosis test ( test perform within 1 year enrollment ) , unless previously vaccinate BacilleCalmetteGu√©rin history adequate chemoprophylaxis Any active infection would normally exclude transplantation Recipients multiple organ transplant Donor age &gt; 60 &lt; 6 year donor whose heart beat Recipients underlie renal disease ( due risk rapid disease recurrence allograft ) : focal segmental glomerulosclerosis , Type I II membranoproliferative glomerulonephritis , hemolytic uremic syndrome/ thrombotic thrombocytopenic purpura A positive Tcell lymphocytoxic crossmatch use donor lymphocyte recipient serum A history true allergy intravenous iodinated roentgenographic contrast agent Participants life expectancy severely limited disease state underlying medical condition A history cancer ( nonmelanoma skin cell cancer cure local resection ) within last 5 year Mammogram film clinically significant abnormality require investigation biopsy History substance abuse ( drug alcohol ) psychotic disorder compatible adequate study followup A currently function , nonrenal transplant Previous treatment basiliximab reason Active peptic ulcer disease , chronic diarrhea , gastrointestinal malabsorption Those use investigational drug within 30 day Day 1 visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>kidney</keyword>
	<keyword>transplant</keyword>
	<keyword>rejection</keyword>
</DOC>